EUCROF27 Archives - EUCROF Conference 2027

Jessica is a highly accomplished and dedicated professional with over 20 years of experience as Director Site Management within the Contract Research Organization (CRO) industry. With her extensive knowledge of clinical trial management, regulatory compliance, and operational efficiency, she has consistently led cross-functional teams to successfully execute numerous clinical trials and studies. Her warm and approachable nature fosters a harmonious work atmosphere that encourages open communication and teamwork.

In her current role as Global Site Activation and Monitoring Head for Benelux , Jessica upholds the highest standards of quality and compliance for the Clinical Operations team in the Benelux region. She consistently seeks opportunities for process improvement and implements innovative strategies to enhance efficiency and mitigate risks in clinical operations. Maintaining close collaboration with local sponsor affiliates, she drives project success through effective communication and partnerships.

Jessica’s journey in Clinical Research began in March 2004 and she has held various critical positions including Clinical Trials Assistant, Clinical Research Associate, Dedicated Trip Report Reviewer, RSU Team Lead, Clinical Operations Manager and Associate Director. Throughout her career, she has been responsible for the full lifecycle of clinical trials, from start-up (feasibilities & site-ID) to project close-out and review.

With extensive expertise spanning full range of therapeutic indications and Medical devices, Jessica has demonstrated her ability to handle diverse clinical research areas with excellence.

Moreover, Jessica actively participates in global initiatives, including strategic site relationships, early talent training programs, CRA training improvements, and risk-based monitoring roll-out models. Her commitment to professional development and industry advancements is evident through her leadership in the Site Management Line Manager forums.

Peter Casteleyn, MSc i~HD

Peter Casteleyn, MSc, is a Technology Director whose mantra is enabling business to work smarter. With a career of over 24 years in the pharmaceutical industry, Peter has made significant contributions across various domains, including Commercial, Supply Chain, Development and Analytics. His work places him at the forefront of technological innovation in the field as he contributed to and triggered cross-industry collaborations in the area of bridging clinical care with clinical research.

End 2024, Peter retired from Johnson & Johnson after the successful introduction of a scalable Electronic Health Records integration capability. Since then, he joined the European Institute for Innovation through Health Data (I~HD) as clinical data strategy advisor, co-leading initiatives as the eSource scale-up Taskforce and parts of European Commission funded initiatives bridging clinical care and clinical research. He firmly believes in the importance of insights from data for the health care industry supported by the interoperability of health data and that industry wide collaboration is the key to achieve this.

Marcello Milano BioMarin

Marcello Milano is a director in the R&D and Regulatory Policy team at BioMarin, a global biotechnology company that develops innovative therapies for rare genetic diseases. In his role, Marcello focuses on EU regulatory intelligence, regulatory policy development and advocacy as a member of working groups across industry organizations, including EuropaBio, EUCOPE, ARM, MPP and BIA. Amongst other roles, he acts as EUCOPE alternate in the Accelerating Clinical Trials in Europe (ACT-EU) Multistakeholder Platform Advisory Group.

Marcello has been part of the biopharmaceutical industry for about 30 years, of which nearly 20 in the regulatory affairs field, with previous roles in Chiesi and GSK. He holds a chemistry degree from the University of Padua, Italy.